NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment

Summary

Vanda Pharmaceuticals announced that NEREUS (tradipitant), the first new prescription medication approved for motion sickness prevention in 47 years, will sponsor the No. 47 IndyCar entry. The announcement marks a marketing initiative for the FDA-approved drug.